The original is one click away. Open original ↗
How first-time founders avoid early-stage mistakes in healthtech
Executive overview
Most early-stage founders ask partners what they want, then build it — but partners rarely know what's technologically possible. The real job is finding the pain point first, then letting the technology serve it.
Pelu Tran co-founded two health-AI companies, pivoted through the death of Google Glass, survived COVID as a non-COVID healthcare startup, and closed a $31M raise. His hard-won rules: anchor to endemic problems, not hype cycles; qualify your customers ruthlessly; stay comfortable being wrong for years.
The fatal mistake is building a technology in search of a problem — survival requires finding a problem big enough to outlast any single technology.
Starting with pain, not technology
- AugmentX began as a side project, but survived because it found a genuinely large problem: documentation burden killing physician time
- Google Glass died; the mission didn't — a tablet-based version shipped quickly because the problem, not the product, was the anchor
- Technology-first companies get far then fail; problem-first companies can pivot and persist
- Gen AI will change the world, but on a longer timeline than any single startup can weather — hype always overestimates near-term impact
Validating before building
- De-risk assumptions manually first — an Excel spreadsheet or a human in the loop is enough to test core hypotheses
- Ferrum ran an open-source lung nodule model across hospital scans for three days and found ~50 missed findings, proving urgency before building a full platform
- Founders over-index on building good technology; the priority is identifying the exact pinpoint problem
Qualifying customers ruthlessly
- Partners can identify their problems; they cannot tell you the solution — go in to listen, not to take orders
- Be explicit about what you solve: "We solve the security problem and the patient safety problem — if those aren't your problems, we're not the right fit"
- Walking away from revenue is hard, but customers who care about the exact problem you solve become trusted advisors, not just accounts
- Different hospitals have different primary motivations — align around their stated pain, not a generic pitch
Surviving when nobody cares
- COVID devastated most healthcare companies not directly solving COVID; Ferrum was one of them
- Keeping teams, investors, and customers aligned through years of zero market enthusiasm is a distinct, underrated skill
- Staying focused on the original thesis meant being perfectly positioned when AI became a priority for hospitals
- Comfort with being wrong publicly — for years — is non-negotiable for founders; no iconic company was universally believed in at the start
First-time founder disadvantages and how to overcome them
- Starting young means lower risk tolerance later — the right time to start is early, before risk appetite drops
- Youth brings knowledge gaps and weak networks, but both are solvable through diligence and open-minded networking
- The trade-off of leaving medicine was real — classmates became high-powered surgeons; the consolation is impact at scale, not at bedside
More like this — when you're ready for early access.
Join the waitlist for a personal account and content recommendations based on what you're working on.
No spam. Unsubscribe at any time.
You're on the list. We'll be in touch before launch.